NCT04047303View on ClinicalTrials.gov

CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 2, 2020

Primary Completion Date

June 3, 2024

Study Completion Date

June 3, 2024

Conditions
AstrocytomaGlioblastoma
Interventions
DRUG

CC-90010

CC-90010

Trial Locations (4)

28040

Local Institution - 302, Madrid

28041

Local Institution - 301, Madrid

33612

Local Institution - 101, Tampa

02215

Local Institution - 102, Boston

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT04047303 - CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma | Biotech Hunter | Biotech Hunter